Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ERYTECH Pharma S.A. Regulatory Filings 2016

Feb 8, 2016

1295_dva_2016-02-08_c0e8aea9-dc99-41c5-89d3-0a80962b0def.pdf

Regulatory Filings

Open in viewer

Opens in your device viewer

Information related to total number of voting rights and shares composing the share capital January 2016

Article 223-16 of general regulation of French Autorité des Marchés Financiers Lyon - France

Listing market: Euronext Paris from Euronext Market segment : segment B ISIN Code : FR0011471135 website : www.erytech.com

Date Total of shares composing Total of brut(1) voting Total of net(2) voting
the share capital rights rights
31 January 2016 7 924 611 9 706 437 9 703 937

(1) Gross voting rights number (or « theoretical » voting rights) is used as a calculus base for the crossing of the threshold. In accordance with article 223-11 of general regulation of Autorité des Marchés Financiers, this number is calculated on the basis of all shares carrying the single and double voting rights, including shares without voting rights.

(2) Without treasury shares